Clinical Trials of Drugs and Biopharmaceuticals
Editat de Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee, Mei-Ling Chenen Limba Engleză Hardback – 19 sep 2005
Practical and informative, this step-by-step guide includes information on all four phases of clinical trials prior to licensure and covers the design of post-marketing studies. The editors examine how recent advances and increased demand for safer and more effective drugs have changed the process by which drugs are developed and approved.
Preț: 1415.85 lei
Preț vechi: 1900.76 lei
-26% Nou
Puncte Express: 2124
Preț estimativ în valută:
271.16€ • 279.37$ • 227.15£
271.16€ • 279.37$ • 227.15£
Comandă specială
Livrare economică 01-15 februarie
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780849321856
ISBN-10: 0849321859
Pagini: 518
Ilustrații: 11 b/w images and 50 tables
Dimensiuni: 178 x 254 x 32 mm
Greutate: 1.09 kg
Ediția:Revised
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
ISBN-10: 0849321859
Pagini: 518
Ilustrații: 11 b/w images and 50 tables
Dimensiuni: 178 x 254 x 32 mm
Greutate: 1.09 kg
Ediția:Revised
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
Public țintă
ProfessionalCuprins
Preparation for Clinical Trials. Regulatory Organization and Decision Making. Evaluation and Quality Assurance of Drugs and Biopharmaceuticals. Future Perspectives in Drug Development
Recenzii
“This book is useful because it consolidates information from preclinical and clinical fields and also adds the perspective of regulatory agencies in bringing drugs to market…definitely is more ambitious than the previous edition.”
—Alan Poisner, M.D., Doody’s Book Review Service
“This volume provides an overview of current procedures and major issues involved in drug and biopharmaceutical development. The book examines critical biochemical and pharmaceutical considerations for trials conducted during each phase of clinical development. It also reports information related to early pre-clinical evaluations of pharmacological activities and safety before proceeding with the initiation of clinical trials. … Practical and informative, this step-by-step guide includes information on all four phases of clinical trials prior to licensure and covers the design of post-marketing studies. The editors examine how recent advances and increased demand for safer and more effective drugs have changed the process by which drugs are developed and approved.”
— In Anticancer Research, Vol. 26, 2006
—Alan Poisner, M.D., Doody’s Book Review Service
“This volume provides an overview of current procedures and major issues involved in drug and biopharmaceutical development. The book examines critical biochemical and pharmaceutical considerations for trials conducted during each phase of clinical development. It also reports information related to early pre-clinical evaluations of pharmacological activities and safety before proceeding with the initiation of clinical trials. … Practical and informative, this step-by-step guide includes information on all four phases of clinical trials prior to licensure and covers the design of post-marketing studies. The editors examine how recent advances and increased demand for safer and more effective drugs have changed the process by which drugs are developed and approved.”
— In Anticancer Research, Vol. 26, 2006
Notă biografică
Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee, Mei-Ling Chen
Descriere
Based on the bestselling Handbook of Phase I/II Clinical Drug Trials, this newly named, completely revised and expanded volume details how recent advances and increasing demands for safety and efficacy have changed the process by which drugs are developed and approved. It examines critical considerations for trials conducted during each phase of clinical development. It also explores early pre-clinical evaluations of pharmacological activity and safety. Ten sections examining clinical assessment are organized according to anatomical targets (e.g. CNS, liver), functions (e.g. metabolic, chemotherapeutic) with another section covering vaccines, biotechnology-derived therapeutics, and plant-based medicines.